Tagreed Alkaltham: Fibrinogen Concentrate Is a Deliberate Clinical Choice in Acute Bleeding
Tagreed Alkaltham, Transfusion Medicine Lab Supervisor at KSMC, shared a post on LinkedIn:
“Fibrinogen concentrate is not a shortcut.
It’s a deliberate clinical choice.
In acute bleeding, fibrinogen concentrate is often discussed in terms of speed and convenience. But its real value is not how fast it can be given – it’s when and why it is given. It’s when fibrinogen deficiency is addressed, and why supporting clot stability early matters.
Fibrinogen concentrate provides a known, standardized dose, without the volume burden or preparation time associated with cryoprecipitate. In critical bleeding, knowing what to expect makes the decision safer.
It’s not that fibrinogen’s role in coagulation is unknown; the difference lies in how early it is addressed, before bleeding escalates into loss of control.
When used appropriately, it allows teams to:
- correct hypofibrinogenemia promptly
- avoid unnecessary volume overload
- and target the hemostatic deficit more precisely
From a blood bank perspective, fibrinogen concentrate represents a shift in thinking: from reactive transfusion
to intentional hemostatic management.
From a blood bank perspective, fibrinogen concentrate also offers operational clarity. It reduces pressure on cryoprecipitate stock, which is often limited, variable in availability, and time sensitive once thawed. Its longer shelf life allows for better inventory stability, without compromising readiness for true bleeding emergencies.
It requires clear protocols, shared clinical understanding, and respect for timing.
- Used thoughtfully, it strengthens care.
- Used casually, it becomes just another product.
In bleeding patients, precision is not a luxury – it is part of patient safety.Its value lies in judgment, not availability.”
Other posts featuring Tagreed Alkaltham on Hemostasis Today.
-
Feb 22, 2026, 09:38Abdulrahman Nasiri: Significant Shifts In The 2026 AHA/ACC Guidelines for Acute Pulmonary Embolism
-
Feb 22, 2026, 09:22Shiny K. Kajal: Not All Transfusion Reactions Are Immunohematologic Incompatibilities
-
Feb 22, 2026, 09:12Arun V J։ The Hidden Risks in Every Blood Bag
-
Feb 22, 2026, 08:56Parandzem Khachatryan։ How Hard Is It to Be a Mom, a Wife, a Professor, and a Doctor All at Once?
-
Feb 22, 2026, 08:46Anirban Sen Gupta Presents Bioinspired Platelet Surrogates at MTEC
-
Feb 22, 2026, 08:31Heghine Khachatryan: Advancing Care for Women and Girls with Bleeding Disorders is A Matter of Equity
-
Feb 22, 2026, 08:18Ossama Mansour: The Safety and Clinical Efficacy of Endovascular Therapy in TVAI
-
Feb 22, 2026, 07:46Vallabh Janardhan: Vascular Disease Is Sltimately A Story of Thrombosis
-
Feb 22, 2026, 07:20Leonardo Cardoso: Mechanical Thrombectomy Improves Functional Independence, Outcomes and Reduces Mortality